首页> 外文期刊>Journal of Neurology, Neurosurgery and Psychiatry >Cognitive-behavioural therapy does not meaningfully reduce depression in most people with epilepsy: a systematic review of clinically reliable improvement
【24h】

Cognitive-behavioural therapy does not meaningfully reduce depression in most people with epilepsy: a systematic review of clinically reliable improvement

机译:认知行为治疗不会有意义地减少大多数癫痫的人类抑郁症:对临床可靠改进的系统审查

获取原文
获取原文并翻译 | 示例
           

摘要

Psychological treatment is recommended for depression and anxiety in those with epilepsy. This review used standardised criteria to evaluate, for the first time, the clinical relevance of any symptom change these treatments afford patients. Databases were searched until March 2017 for relevant trials in adults. Trial quality was assessed and trial authors asked for individual participants' pre-treatment and post-treatment distress data. Jacobson's methodology determined the proportion in the different trial arms demonstrating reliable symptom change on primary and secondary outcome measures and its direction. Search yielded 580 unique articles; only eight eligible trials were identified. Individual participant data for five trials-which included 398 (85%) of the 470 participants randomised by the trials-were received. The treatments evaluated lasted similar to 7 hours and all incorporated cognitive-behavioural therapy (CBT). Depression was the primary outcome in all; anxiety a secondary outcome in one. On average, post-treatment assessments occurred 12 weeks following randomisation; 2 weeks after treatment had finished. There were some limitations in how trials were conducted, but overall trial quality was 'good'. Pooled risk difference indicated likelihood of reliable improvement in depression symptoms was significantly higher for those randomised to CBT. The extent of gain was though low-the depressive symptoms of most participants (66.9%) receiving CBT were 'unchanged' and 2.7% 'reliably deteriorated'. Only 30.4% made a 'reliable improvement. This compares with 10.2% of participants in the control arms who 'reliably improved' without intervention. The effect of the treatments on secondary outcome measures, including anxiety, was also low. Existing CBT treatments appear to have limited benefit for depression symptoms in epilepsy. Almost 70% of people with epilepsy do not reliably improve following CBT. Only a limited number of trials have though been conducted in this area and there remains a need for large, well-conducted trials.
机译:建议在癫痫患者中抑郁和焦虑的心理治疗。本综述使用标准化标准,首次评估了这些治疗的任何症状改变的临床相关性。在2017年3月之前搜索数据库,以获得成人的相关试验。评估试验质量和试验作者要求个人参与者的预处理和治疗后遇险数据。雅各布森的方法决定了不同试验臂中的比例,证明了初级和次要结果措施及其方向上可靠的症状变化。搜索产生了580件独特的文章;只确定了八项合格试验。五项试验的个人参与者数据 - 包括试验随机组合的470名参与者的398(85%)。评估的治疗持续到7小时和全部掺入的认知行为治疗(CBT)。抑郁症是所有的主要结果;焦虑一对一的次要结果。平均后,随机化后12周发生治疗后的评估;治疗完成后2周。如何进行试验的局限性,但整体审判质量是“好”。汇总风险差异表明抑郁症状的可靠性改善对于随机转移的症状显着高。收益的程度虽然低 - 大多数参与者的抑郁症状(66.9%)接受CBT的“不变”和2.7%'可靠恶化'。只有30.4%的人取得了“可靠的改善”。这与控制臂的10.2%的参与者相比,他们在没有干预的情况下'可靠地改善'。治疗对次要结果措施(包括焦虑)的影响也很低。现有的CBT治疗似乎对癫痫中的抑郁症状有限的益处。癫痫的近70%的人在CBT后无法可靠地改善。只有有限数量的试验,虽然在这一领域进行了,但仍有需要大型,进行良好的试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号